Pulse Biosciences, Inc.

Robbins LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders

June 25, 2018 (San Diego, CA & Hayward, CA) – Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. (PLSE) breached their fiduciary duties to shareholders. Pulse Biosciences, a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation technology.

Pulse Biosciences, Inc. (PLSE) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can send us a message via the
Shareholder Information form below.

Send us a message for more information.

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started